| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Tg Therapeutics, Inc.'s insiders have reduced their positions by a net 5,000 shares worth roughly $275K.
Classified under Biotechnology (Health Care sector), TGTX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 9.78M | - | - | |
| CFO | 798.1K | - | - | |
| Dir | 168.6K | $9.27M | - | |
| Dir | 8.3K | - | - | |
| Dir | 8.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Charney Laurence N | Director | Sell | 5,000 | $54.96 | $274,800.00 | -2.9% | - | - | |
| Nov 24, 2025 | Echelard Yann49 | Director | Sell | 5,000 | $32.57 | $162,850.00 | -2.2% | -4.6% | - | |
| Sep 11, 2025 | Lonial Sagar | Director | Sell | 20,852 | $32.24 | $672,268.48 | -18.1% | -5.7% | - | |
| Jun 13, 2025 | Echelard Yann49 | Director | Sell | 10,000 | $36.94 | $369,400.00 | -4.2% | -9.9% | +37.5% | |
| Jan 6, 2025 | Power Sean A60 | CFO | Sell | 21,358 | $29.47 | $629,382.29 | -3.1% | +33.0% | +5.0% | |
| Nov 11, 2024 | Charney Laurence N | Director | Sell | 25,000 | $30.20 | $754,875.00 | -10.5% | +4.9% | +1.2% | |
| Nov 11, 2024 | Lonial Sagar | Director | Sell | 5,000 | $30.44 | $152,200.00 | -4.8% | +4.9% | +1.2% | |
| Nov 5, 2024 | Echelard Yann49 | Director | Sell | 20,000 | $24.48 | $489,600.00 | -8.2% | +21.7% | +31.6% | |
| Jun 20, 2024 | Lonial Sagar | Director | Sell | 25,933 | $16.69 | $432,888.91 | -19.8% | +48.7% | +112.1% | |
| Mar 13, 2024 | Lonial Sagar | Director | Sell | 5,000 | $15.94 | $79,675.00 | -4.4% | +2.7% | +135.6% |